# Efficacy and Safety of Teriflunomide in Multiple Sclerosis across Age Groups: Analysis from Pooled Pivotal and Real-world Studies

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-teriflunomide-in-multiple-sclerosis-across-age-groups/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jiwon Oh,Sandra Vukusic,Klaus Tiel‐Wilck,Jihad Inshasi,David Rog,Darren P. Baker,Yelena Pyatkevich,Elizabeth M. Poole,Patrick Vermersch |
| Citations | 10 |
| DOI | 10.1177/11795735211028781 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.1177/11795735211028781 |
| OpenAlex ID | https://openalex.org/W3191178877 |
| PMID | 34377047 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Yelena Pyatkevich](https://scholariq.org/researchers/yelena-pyatkevich/)

## Paper primary topic

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)

## Paper topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.